KYRA GAMBREL: Open Payments
NPI 1083929236 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 53 payments from 10 companies in 2025. Trend: 2023 $741 · 2024 $716 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $230 |
| E.R. Squibb & Sons, L.L.C. | 12 | $181 |
| PFIZER INC. | 11 | $181 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $98 |
| Merck Sharp & Dohme LLC | 5 | $92 |
| Novo Nordisk Inc | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Boston Scientific Corporation | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $33 |
Products named: ELIQUIS, LEQVIO, LifeVest, VERQUVO, CAMZYOS, Wegovy, Kerendia, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across KY — which companies pay providers there.
